Novo Nordisk sues Eli Lilly over ‘misleading’ GLP-1 advertising

Novo Nordisk claims that Lilly’s advertising campaigns intentionally used outdated studies to offer “proof of broad, product-level superiority” of its Zepbound and Mounjaro products over Novo Nordisk’s Wegovy and Ozempic products.…